IC
Immuneering Corp
🇺🇸XNAS.IMRXUnited StatesHealthcare
$4.47USDup +0.01 (+0.22%)OpenDelayed3:24 PM
Price$4.47+0.01 (+0.22%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45254E1073
- CUSIP
- 45254E107
Company
- Employees
- 57
- Headquarters
- Cambridge, United States
- Website
- https://immuneering.com
- CEO
- Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Market
- Shares outstanding
- 64.7M
- Market cap
- $289.2M
Highlights
- Market cap
- $288.55M
- EPS LTM
- -$0.89
- P/E LTM
- -5.60
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $360.96K-50.3%down year on year
- Net income
- -$57.28M+7.81%up year on year
- Gross margin
- -193.62%-1,396.95%down year on year
- Free cash flow
- -$56.99M-10.59%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.